Update on the management of giant cell arteritis

被引：10

作者：

Roberts, Janet ^{[1
]}

Clifford, Alison ^{[1
]}

机构：

[1] Univ Alberta, Dept Med, Div Rheumatol, 8-130K Clin Sci Bldg, Edmonton, AB T6G 2G3, Canada

来源：

THERAPEUTIC ADVANCES IN CHRONIC DISEASE | 2017年 / 8卷 / 4-5期

关键词：

abatacept; giant cell arteritis; tocilizumab; treatment; VARICELLA-ZOSTER-VIRUS; ISCHEMIC OPTIC NEUROPATHY; PLACEBO-CONTROLLED TRIAL; LARGE-VESSEL INVOLVEMENT; TUMOR-NECROSIS-FACTOR; TEMPORAL ARTERY; DOUBLE-BLIND; TAKAYASU ARTERITIS; TOCILIZUMAB; VZV;

D O I：

10.1177/2040622317700089

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Giant cell arteritis (GCA) is a large vessel vasculitis that may be associated with significant complications such as blindness, stroke, or aortic aneurysm and dissection in a subset of patients. Given the serious side effects associated with prolonged courses of glucocorticoids and frequent relapses experienced when doses are tapered, increased efforts are being dedicated to the discovery of safer and more effective therapies to control this disease. The purpose of this review is to critically evaluate the role of glucocorticoid-sparing agents in the medical management of GCA with a special focus on the most recent evidence regarding the role of biologic agents, including tocilizumab (TCZ), abatacept and ustekinumab, and other novel therapies.

引用

下载

页码：69 / 79

页数：11

共 50 条

[31] Management of giant cell arteritis and polymyalgia rheumatica
Meskimen, S
Cook, TD
Blake, RL
AMERICAN FAMILY PHYSICIAN, 2000, 61 (07) : 2061 - 2068
[32] Ultrasound in the diagnosis and management of giant cell arteritis
Schmidt, Wolfgang A.
RHEUMATOLOGY, 2018, 57 : 22 - 31
[33] Updates in the Diagnosis and Management of Giant Cell Arteritis
Uppal, Surabhi
Hadi, Mohanad
Chhaya, Sheetal
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2019, 19 (09)
[34] Giant cell arteritis: Diagnosis and therapeutic management
Gonzalez-Gay M.A.
Garcia-Porrua C.
Miranda-Filloy J.A.
Current Rheumatology Reports, 2006, 8 (4) : 299 - 302
[35] Giant cell arteritis: Current treatment and management
Cristina Ponte
Ana Filipa Rodrigues
Lorraine O'Neill
Raashid Ahmed Luqmani
World Journal of Clinical Cases, 2015, 3 (06) : 484 - 494
[36] The diagnostics and management of patients with giant cell arteritis
Gonzalez-Gay, MA
JOURNAL OF RHEUMATOLOGY, 2005, 32 (07) : 1186 - 1188
[37] Giant Cell Arteritis and Polymyalgia RheumaticaPathophysiology and Management
Miguel A. Gonzalez-Gay
Carlos Garcia-Porrua
Jose A. Miranda-Filloy
Javier Martin
Drugs & Aging, 2006, 23 : 627 - 649
[38] Giant-cell arteritis. Update: diagnosis and therapy
Schirmer, M.
Dejaco, C.
Schmidt, W. A.
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2012, 71 (09): : 754 - +
[39] Recent advances in the clinical management of giant cell arteritis and Takayasu arteritis
Koster, Matthew J.
Matteson, Eric L.
Warrington, Kenneth J.
CURRENT OPINION IN RHEUMATOLOGY, 2016, 28 (03) : 211 - 217
[40] FAST TRACK GIANT CELL ARTERITIS CLINIC AND PATHWAY FOR EARLY MANAGEMENT OF SUSPECTED GIANT CELL ARTERITIS: AN AUDIT
Laskou, Faidra
Fiona, Coath
Aung, Tin
Benerjee, Siwalik
Dasgupta, Bhaskar
RHEUMATOLOGY, 2018, 57

← 1 2 3 4 5 →